A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis is a research paper published in Science Translational Medicine (2023). On theSindex it has a DataRank of 0.434. It has been cited 17 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.434
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Crohn's & Colitis Foundation
Grant: 551813
NIGMS NIH HHS
Grant: R25 GM143298
NIGMS NIH HHS
Grant: T32 GM135083
NIH HHS
Grant: T32 OD011089
NCCIH NIH HHS
Grant: K01 AT010984
NIH HHS
Grant: K01 OD030517
Crohn's & Colitis Foundation
Grant: 681795
National Institutes of Health
Grant: 5K01OD030517-03
Exploring Glutamate Carboxypeptidase II (GCPII) Dysregulation in Human and Experimental IBD
National Institutes of Health
Grant: 5R25GM143298-03
The 'Career MODE' Program: Careers through Mentoring and training in Omics and Data for Early-stage investigators
National Institutes of Health
Grant: 2T32OD011089-39
Training Veterinarians for Careers in Biomedical Research
National Institutes of Health
Grant: 5K01AT010984-05
Exploring a natural product to modulate aberrant gut bacterial-fungal interactions as pathological mechanisms underlying HIV-associated depression
FWCI
2.80
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals